Sources
- James Cook University. Northern Queensland faces rising mosquito-borne virus threat. 13 Feb 2026
- Australia’s Northern Queensland mosquito-borne virus threat escalates. Xinhua News Agency. 13 Feb 2026
- Ross River virus cases quadruple in South Australia in 2025. ABC News. 23 Jan 2026
- Hosen ME, et al. Mosquito-borne viruses in Australia: An emerging trend of increasing prevalence in Northern Queensland. Virology. 2026;617:110825
Key findings
- Ross River virus (RRV) activity remains elevated in Australia, with continued transmission into 2026, consistent with increasingly favorable environmental conditions for mosquito vectors. RRV disease is an illness transmitted primarily by mosquito bites and characterized by arthralgia, myalgia, and febrile symptoms with rash.
- Ross River virus notifications reported in 2025 include high burdens across several jurisdictions, notably Queensland (654), New South Wales (502 cases), Western Australia (435), Victoria (187), South Australia (109), the Northern Territory (61), and the Australian Capital Territory (<5) (National Notifiable Disease Surveillance System (NINDSS) Dashboard).
- South Australia shows a marked increase in Ross River virus notifications in 2025 compared with recent years, with cases concentrated in environmentally suitable regions such as the Riverland and the northern Adelaide Plains.
- The widespread geographic distribution of Ross River virus across multiple states highlights its entrenched endemic status and the ongoing public health impact of this disease.
- More than 900 unclassified flaviviruses have been detected across Australia over recent decades, indicating significant gaps in current detection systems.
Epidemiological analysis and public health impact
- The sustained transmission of Ross River virus into 2026 is a significant public health concern and reflects broader environmental and ecological shifts that increasingly favor mosquito proliferation. Climate variability and warming temperatures are extending the seasonal window for Ross River virus transmission beyond the traditional summer period, while altered rainfall patterns are creating more persistent larval habitats across urban, peri-urban, and rural settings.
- Urban expansion and land-use change are increasing human exposure to competent mosquito vectors and wildlife reservoir hosts, particularly in regions such as coastal New South Wales, northern and eastern Victoria, South Australia’s Riverland, and parts of Western Australia. These dynamics facilitate ongoing spillover of Ross River virus from animal reservoirs to human populations, sustaining transmission even in the absence of large, explosive outbreaks.
- Unlike arboviruses that are limited to specific mosquito species or ecological niches, Ross River virus is transmitted by a broad range of mosquito vectors. This ecological flexibility complicates control efforts, places sustained pressure on surveillance systems, and contributes to the virus’s persistence across diverse climatic zones in Australia.
- The detection of more than 900 unclassified flaviviruses nationwide reveals critical surveillance gaps that may allow novel or reemerging pathogens to circulate undetected. Current PCR (polymerase chain reaction)-based detection methods are effective only for known pathogens, leaving blind spots for divergent strains or entirely new viruses. This limitation is particularly concerning given Northern Queensland’s proximity to Southeast Asia, a global hotspot for arbovirus emergence and evolution, which facilitates pathogen introduction through travel and trade.
Comparative analysis and future outlook
- The 2025 Ross River virus notification data indicate that the virus continues to cause a substantial disease burden across Australia, with particularly high case numbers in New South Wales and notable increases in South Australia and Victoria. These patterns suggest that Ross River virus transmission is not only persisting but may be expanding geographically and temporally.
- Looking ahead, the risk of further escalation remains elevated. Climate change is likely to continue lengthening transmission seasons, while ongoing urbanization and environmental modification will create additional mosquito breeding habitats and increase human–vector contact. Early warning signals for worsening conditions include sustained year-over-year increases in notifications, expansion into regions with historically low incidence, and earlier seasonal onset of reported cases.
Pathogen characteristics
Ross River virus is an alphavirus endemic to Australia and is maintained in enzootic cycles involving a range of mosquito species and animal reservoir hosts. Humans are incidental hosts and become infected through mosquito bites. Following infection, immunity is generally long-lasting, though reinfection has been reported in rare cases (Australian CDC).
Clinical management
Ross River virus infection typically presents with fever, rash, and debilitating polyarthralgia. Joint pain and fatigue can persist for months or longer, leading to significant reductions in quality of life and work capacity. Management remains supportive, focusing on symptom relief and functional recovery, as no specific antiviral treatment is currently available (Australian CDC).
Acknowledgement
BEACON thanks Dr. med. Sebastian Knorz, Tropical Institute at the LMU Hospital, Munich, Germany, for the submission of cases included in this report. The Tropical Institute at the LMU Hospital in Munich, Germany, is a GeoSentinel site.
Sources
Key findings
Epidemiological analysis and public health impact
Comparative analysis and future outlook
Pathogen characteristics
Ross River virus is an alphavirus endemic to Australia and is maintained in enzootic cycles involving a range of mosquito species and animal reservoir hosts. Humans are incidental hosts and become infected through mosquito bites. Following infection, immunity is generally long-lasting, though reinfection has been reported in rare cases (Australian CDC).
Clinical management
Ross River virus infection typically presents with fever, rash, and debilitating polyarthralgia. Joint pain and fatigue can persist for months or longer, leading to significant reductions in quality of life and work capacity. Management remains supportive, focusing on symptom relief and functional recovery, as no specific antiviral treatment is currently available (Australian CDC).
Acknowledgement
BEACON thanks Dr. med. Sebastian Knorz, Tropical Institute at the LMU Hospital, Munich, Germany, for the submission of cases included in this report. The Tropical Institute at the LMU Hospital in Munich, Germany, is a GeoSentinel site.